204 related articles for article (PubMed ID: 37371067)
1. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo.
Lee-Gosselin A; Jury-Garfe N; You Y; Dabin L; Soni D; Dutta S; Rochet JC; Kim J; Oblak AL; Lasagna-Reeves CA
Cells; 2023 Jun; 12(12):. PubMed ID: 37371067
[TBL] [Abstract][Full Text] [Related]
2. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology.
Lee SH; Meilandt WJ; Xie L; Gandham VD; Ngu H; Barck KH; Rezzonico MG; Imperio J; Lalehzadeh G; Huntley MA; Stark KL; Foreman O; Carano RAD; Friedman BA; Sheng M; Easton A; Bohlen CJ; Hansen DV
Neuron; 2021 Apr; 109(8):1283-1301.e6. PubMed ID: 33675684
[TBL] [Abstract][Full Text] [Related]
3. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency.
Vautheny A; Duwat C; Aurégan G; Joséphine C; Hérard AS; Jan C; Mitja J; Gipchtein P; Gaillard MC; Buée L; Blum D; Hantraye P; Bonvento G; Brouillet E; Cambon K; Bemelmans AP
Neurobiol Dis; 2021 Jul; 155():105398. PubMed ID: 34019997
[TBL] [Abstract][Full Text] [Related]
4. TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy.
Bemiller SM; McCray TJ; Allan K; Formica SV; Xu G; Wilson G; Kokiko-Cochran ON; Crish SD; Lasagna-Reeves CA; Ransohoff RM; Landreth GE; Lamb BT
Mol Neurodegener; 2017 Oct; 12(1):74. PubMed ID: 29037207
[TBL] [Abstract][Full Text] [Related]
5. Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration.
Gratuze M; Leyns CE; Sauerbeck AD; St-Pierre MK; Xiong M; Kim N; Serrano JR; Tremblay MÈ; Kummer TT; Colonna M; Ulrich JD; Holtzman DM
J Clin Invest; 2020 Sep; 130(9):4954-4968. PubMed ID: 32544086
[TBL] [Abstract][Full Text] [Related]
6. TREM2 Agonism with a Monoclonal Antibody Attenuates Tau Pathology and Neurodegeneration.
Fassler M; Benaim C; George J
Cells; 2023 Jun; 12(11):. PubMed ID: 37296669
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
[TBL] [Abstract][Full Text] [Related]
8. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
[TBL] [Abstract][Full Text] [Related]
9. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
[TBL] [Abstract][Full Text] [Related]
10. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
11. Reactive or transgenic increase in microglial TYROBP reveals a TREM2-independent TYROBP-APOE link in wild-type and Alzheimer's-related mice.
Audrain M; Haure-Mirande JV; Mleczko J; Wang M; Griffin JK; St George-Hyslop PH; Fraser P; Zhang B; Gandy S; Ehrlich ME
Alzheimers Dement; 2021 Feb; 17(2):149-163. PubMed ID: 33314529
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.
Sayed FA; Telpoukhovskaia M; Kodama L; Li Y; Zhou Y; Le D; Hauduc A; Ludwig C; Gao F; Clelland C; Zhan L; Cooper YA; Davalos D; Akassoglou K; Coppola G; Gan L
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10172-10177. PubMed ID: 30232263
[TBL] [Abstract][Full Text] [Related]
13. Intersection of pathological tau and microglia at the synapse.
Vogels T; Murgoci AN; Hromádka T
Acta Neuropathol Commun; 2019 Jul; 7(1):109. PubMed ID: 31277708
[TBL] [Abstract][Full Text] [Related]
14. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
[TBL] [Abstract][Full Text] [Related]
15. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
[TBL] [Abstract][Full Text] [Related]
16. TREM2 function impedes tau seeding in neuritic plaques.
Leyns CEG; Gratuze M; Narasimhan S; Jain N; Koscal LJ; Jiang H; Manis M; Colonna M; Lee VMY; Ulrich JD; Holtzman DM
Nat Neurosci; 2019 Aug; 22(8):1217-1222. PubMed ID: 31235932
[TBL] [Abstract][Full Text] [Related]
17. Role of TREM2 in Alzheimer's Disease: A Long Road Ahead.
Kulkarni B; Kumar D; Cruz-Martins N; Sellamuthu S
Mol Neurobiol; 2021 Oct; 58(10):5239-5252. PubMed ID: 34275100
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
19. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
Jiang T; Tan L; Zhu XC; Zhou JS; Cao L; Tan MS; Wang HF; Chen Q; Zhang YD; Yu JT
Neurobiol Aging; 2015 Dec; 36(12):3176-3186. PubMed ID: 26364736
[TBL] [Abstract][Full Text] [Related]
20. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes.
Zhu B; Liu Y; Hwang S; Archuleta K; Huang H; Campos A; Murad R; Piña-Crespo J; Xu H; Huang TY
Mol Neurodegener; 2022 Sep; 17(1):58. PubMed ID: 36056435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
